Sentences with phrase «on people with diabetes»

There is much more data on people with diabetes who take metformin with the majority of the evidence showing metformin decreases B12 levels.
A study was conducted on people with diabetes and was found out that tea helps in reducing blood sugar levels.
More than half of this economic cost (56 %, $ 10.8 billion) was on accessing diabetes treatment, including medication and hospital stays — and one half of these costs were out - of - pocket (paid for by the patients), putting a huge financial burden on people with diabetes.

Not exact matches

The number of people living with diabetes has tripled since 2000, pushing the global cost of the disease to $ 850 billion a year, medical experts said on Tuesday.
«The investment reflects our commitment to our diabetes care business and to improving the lives of people with diabetes,» a Roche spokeswoman said on Friday.
Plenty of people have lived longer than expected with CF (depends on the severity) and some people have had diabetes reversed from changing their lifestyles.
People with diabetes should closely monitor their blood sugar levels because psyllium may have a lowering effect on the glycemic levels.
Effect of non-oil-seed pulses on glycaemic control: a systematic review and meta - analysis of randomised controlled experimental trials in people with and without diabetes.
The leafy greens are filled with magnesium and low on the glycemic index which makes them amazing for people with type 2 diabetes.
CA About Blog Diabetes Health magazine, published by King's Publishing in California, United States, is one of the US's biggest magazines focusing on diabetes and the complications that are the every day concern of people with this disease and also their families and Diabetes Health magazine, published by King's Publishing in California, United States, is one of the US's biggest magazines focusing on diabetes and the complications that are the every day concern of people with this disease and also their families and diabetes and the complications that are the every day concern of people with this disease and also their families and friends.
Such as it is gluten free, low glycemic, has minimal impact on blood sugar, higher in fiber, healthier baking option for people with inflammation diseases such as diabetes (I am type 1), it is not processed and natural... and SOO many more!
Additionally, turmeric has been shown to act on the liver to regulate epigenetic (activation of genes) and enzymatic factors that all work together to stabilize blood sugar and triglyceride levels in people with diabetes.
While studies examining effects of chia on blood sugar control are ongoing, the protein, heart - healthy fats, fiber, and antioxidants found in chia seeds are beneficial for people with diabetes — especially those who want to keep heart - disease risks low and achieve or maintain a healthy weight.
@Jen, actually a person with Type 2 diabetes can indeed have lower levels of insulin depending on where they are on the disease spectrum.
It can be treated with a healthy diet and physical activity but Type 2 diabetes is a progressive condition and people often go on to take medication and insulin injections.
«We saw one person with diabetes who was relying on their medication being sent here from Zimbabwe,» Dr Suntharamoorthy says.
Diabetes UK is concerned that competition will only succeed in creating a more fragmented diabetes care service, which could have dire consequences on the long - term health of people with diabetes and impact on an already over-burdened health serviceDiabetes UK is concerned that competition will only succeed in creating a more fragmented diabetes care service, which could have dire consequences on the long - term health of people with diabetes and impact on an already over-burdened health servicediabetes care service, which could have dire consequences on the long - term health of people with diabetes and impact on an already over-burdened health servicediabetes and impact on an already over-burdened health service budget.
Diabetes UK is the leading charity for over 3.5 million people in the UK with diabetes In 2011, Diabetes UK aims to spend over # 6 million on diabetes research to investigate the causes and prevention of diabetes, to improve care and treatment of diabetes and ultimately to work towardsDiabetes UK is the leading charity for over 3.5 million people in the UK with diabetes In 2011, Diabetes UK aims to spend over # 6 million on diabetes research to investigate the causes and prevention of diabetes, to improve care and treatment of diabetes and ultimately to work towardsdiabetes In 2011, Diabetes UK aims to spend over # 6 million on diabetes research to investigate the causes and prevention of diabetes, to improve care and treatment of diabetes and ultimately to work towardsDiabetes UK aims to spend over # 6 million on diabetes research to investigate the causes and prevention of diabetes, to improve care and treatment of diabetes and ultimately to work towardsdiabetes research to investigate the causes and prevention of diabetes, to improve care and treatment of diabetes and ultimately to work towardsdiabetes, to improve care and treatment of diabetes and ultimately to work towardsdiabetes and ultimately to work towards a cure.
Information: Diabetes UK provides high quality information for people with diabetes and healthcare professionals through leaflets, books and on the IDiabetes UK provides high quality information for people with diabetes and healthcare professionals through leaflets, books and on the Idiabetes and healthcare professionals through leaflets, books and on the Internet.
Access to medication and treatments Diabetes UK believes that people with diabetes should have equal access to the best diabetes care and health outcomes available on the basis of clinical need and appropriateness, not on their or the NHS's abilityDiabetes UK believes that people with diabetes should have equal access to the best diabetes care and health outcomes available on the basis of clinical need and appropriateness, not on their or the NHS's abilitydiabetes should have equal access to the best diabetes care and health outcomes available on the basis of clinical need and appropriateness, not on their or the NHS's abilitydiabetes care and health outcomes available on the basis of clinical need and appropriateness, not on their or the NHS's ability to pay.
Self - monitoring of blood glucose People with Type 1 and Type 2 diabetes should have access to self - monitoring of blood glucose (SMBG) based on individual clinical need, type of diabetes, personal circumstances and informed consent - not on ability to pay..
• # 600m each year goes on treating foot problems in people with diabetes in the UK, and at least # 252m of this is spent on amputation.
Emphasis should be placed on funding research in areas that will make a difference to the lives of people with diabetes their parents and carers, in the short -, medium - and longer term.
Ensuring access to high quality care for people with diabetes Diabetes UK and the Association of British Clinical Diabetologists (ABCD) believe that all people with diabetes should have equal access to the best possible diabetes care and health outcomes provided on the basis of clinicadiabetes Diabetes UK and the Association of British Clinical Diabetologists (ABCD) believe that all people with diabetes should have equal access to the best possible diabetes care and health outcomes provided on the basis of clinicaDiabetes UK and the Association of British Clinical Diabetologists (ABCD) believe that all people with diabetes should have equal access to the best possible diabetes care and health outcomes provided on the basis of clinicadiabetes should have equal access to the best possible diabetes care and health outcomes provided on the basis of clinicadiabetes care and health outcomes provided on the basis of clinical need..
It is unacceptable for people with diabetes to be deprived of (new) developments because of «postcode prescribing» where access to treatment depends on where the individual lives or from whom they receive their diabetes care..
Diabetic retinopathy is the leading cause of blindness in the country's working - age population and leading health charity Diabetes UK warns that blindness is just one complication that people with diabetes could be at risk of because they are missing out on a wide range of health checks and specialist sDiabetes UK warns that blindness is just one complication that people with diabetes could be at risk of because they are missing out on a wide range of health checks and specialist sdiabetes could be at risk of because they are missing out on a wide range of health checks and specialist services.
People with diabetes, including children and young people, should have access to insulin pumps and other technological innovations to help them manage their condition on a day to day bPeople with diabetes, including children and young people, should have access to insulin pumps and other technological innovations to help them manage their condition on a day to day bpeople, should have access to insulin pumps and other technological innovations to help them manage their condition on a day to day basis..
During our 75th Anniversary year, we hope you will be able to join in and support us so that we can carry on improving the lives of people with diabetes into the future.
«This could lead to a new therapeutic strategy for treating type 2 diabetes,» says Stanford, whose team believes that the drug could lead to fewer people with adult - onset diabetes becoming dependent on insulin injections.
He went there to work on a «smart» contact lens for people with diabetes that measures the level of glucose in tears.
Medical diagnostics is getting better all the time, says Robert Langer, an engineer at MIT who has set up a company that uses ultrasound to let people with diabetes collect data on their glucose levels.
We believe the findings indicate the importance of healthcare professionals focusing on the emotional states of young people with diabetes, as well as their physical condition.»
The researchers say their findings also shed new light on how kidney disease leads to an abnormal thickening of heart muscle tissue called hypertrophy, which is a leading cause of death in people with kidney disease caused by high blood pressure, diabetes, and other illnesses.
People with type 2 diabetes admitted to the hospital for heart failure faced a 24 to 28 percent chance of death during the remainder of the trial, on aloglipin or placebo respectively.
Health is high on the agenda in many countries with efforts to get more people exercising in order to reduce the problems associated with obesity, such as diabetes, cardiovascular disease and cancer.
After adjusting the data for age, sex, race, education, smoking, alcohol use, blood pressure, diabetes, high blood pressure medication, cholesterol levels, statin use and body mass index, the researchers found that those people who met both the recommended activity levels and had vitamin D levels above 20 nanograms per milliliter experienced about a 23 percent less chance of having an adverse cardiovascular event than those people with poor physical activity who were deficient for vitamin D. On the other hand, people who had adequate exercise but were vitamin D deficient didn't have a reduced risk of an adverse event.
Belviq has also shown promise for people with type 2 diabetes, who were twice as likely to keep their blood sugars under control than those on the placebo.
The Monash University study, led by Emeritus Professor Paul O'Brien and Dr John Wentworth from the Centre for Obesity Research and Education (CORE), has determined that weight loss surgery (gastric banding) for overweight people with diabetes had a profound impact on the illness.
Researchers from The University of Manchester in collaboration with Keele and Southampton Universities have published new findings which shed light on the poor outcomes of South Asian people with diabetes in the UK.
The results showed that normal physical fitness, even up to 20 % below the population average, is sufficient to have a preventive effect on five of the eight risk factors affecting people with cardiovascular disease — abdominal circumference, diabetes, hypertension, obesity, and excess weight.
A Southampton study using high resolution imaging to create a «virtual bone biopsy» has shed new light on why people with type 2 diabetes are at risk of bone fractures.
This recommendation was based on the ability of screening to identify persons with diabetes and evidence that more - intensive blood pressure treatment was associated with reduced risk for cardiovascular events, including cardiovascular mortality, in patients with diabetes and hypertension.
According to the National Institute of Diabetes and Digestive and Kidney Diseases, each year more than 15,000 children and 15,000 adults — roughly 80 people per day — are diagnosed with the disease in the U.S. And the numbers are on the rise: according to the U.S. Centers for Disease Control and Prevention, the disease's prevalence in Americans under age 20 rose by 23 % between 2001 and 2009.
The combination of all these factors together places a burden on people with type 1 diabetes to constantly monitor their glucose levels, to ensure they don't end up with too much blood sugar (hyperglycaemic) or more commonly, too little (hypoglycaemic).
The researchers found that people with Type 1 diabetes were 38 per cent less likely to experience severe hypoglycemia, on average.
The finding builds on an earlier surprise from the Joslin Medalist Study program, which looks for clues on how some people live with type 1 diabetes for more than 50 years with unusually low levels of complications, says George King, M.D., Joslin's Chief Scientific Officer and Professor of Medicine at Harvard Medical School.
People with diabetes who rely on insulin have seen the cost of that drug triple in just a decade — even as doctors have prescribed higher doses to drive down their blood sugar levels.
What's interesting is that there has been a study looking at people who are on this drug that found that some of the people with diabetes that were taking metformin were actually living longer than their non-diabetic counterparts.
«The problem arises from autoimmunity, a condition that people with type 1 diabetes already have,» says Myra A. Lipes, M.D, investigator in the Section on Immunology at Joslin and principal investigator of a study published in the June 13 edition of the journal Science Translational Medicine.
If we could find therapies that detect complications at an early stage, people with diabetes could lead healthier, more productive lives,» says senior author Rohit Kulkarni, M.D., Ph.D., Principal Investigator in the Section on Islet Cell and Regenerative Biology at Joslin Diabetes Center and Associate Professor of Medicine at Harvard Medicaldiabetes could lead healthier, more productive lives,» says senior author Rohit Kulkarni, M.D., Ph.D., Principal Investigator in the Section on Islet Cell and Regenerative Biology at Joslin Diabetes Center and Associate Professor of Medicine at Harvard MedicalDiabetes Center and Associate Professor of Medicine at Harvard Medical School.
a b c d e f g h i j k l m n o p q r s t u v w x y z